Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
anticonvulsants
anticonvulsants, absorption
anticonvulsants, bioavailability
anticonvulsants, blood level determination of
anticonvulsants, brand name
anticonvulsants, cognitive function with
anticonvulsants, compliance
anticonvulsants, discontinuation in seizure-free epileptics
anticonvulsants, dosage
anticonvulsants, effectiveness
anticonvulsants, generic
anticonvulsants, parenteral administration
anticonvulsants, pharmacokinetics
anticonvulsants, selection of
anticonvulsants, subtherapeutic
anticonvulsants, untoward effects of
benzodiazepine
brand name drug
breast feeding
carbamazepine
carbamazepine, controlled release
carbamazepine, toxicity
children
clonazepam
compliance
complications
congenital birth defects
congenital malformation
counselling
dilantin
dilantin, serum level
drug induced neurologic disorders
drug interactions
efficacy
epilepsy referral centers
fetus
folic acid
fosphenytoin
gabapentin
generic drugs
genetic counselling
hepatic failure
immunosuppression
lamotrigine
levetiracetam
liver disease
medical-legal aspects of neurology
midazolam
mylan
mysoline
neural tube defect
neurologic complications of, systemic disease
organ transplantation
phenobarbital
pregnancy, neurologic complications in
propofol
recurrent
renal failure
review article
risk factors
sedation
seizure
seizure, breakthrough
seizure, children
seizure, classification of
seizure, drug-induced
seizure, intractable
seizure, intractable, treatment of
seizure, non-treatment of
seizure, pregnancy
seizure, recurrent
seizure, systemic disease causing
seizure, treatment of
seizure, treatment of, first
seizure, treatment of, monotherapy
sodium valproate
spina bifida
status epilepticus
treatment of neurologic disorder
uremia
weaning from respirator, failure to
zarontin
Showing articles 450 to 500 of 1447 << Previous Next >>

Prognosis for Seizure Recurrence in Patients with Newly Diagnosed Neurocysticercosis
Neurol 59:1730-1734,1669, Carpio,A. &Hauser,W.A., 2002

Poststroke Seizures
Arch Neurol 59:195-202, Silverman,I.E.,et al, 2002

Refractory Status Epilepticus
Arch Neurol 59:205-210,188, Mayer,S.A.,et al, 2002

Chronic Diarrhea Associated with Vagal Nerve Stimulation
Neurol 58:330, Sanossian,N. &Haut,S., 2002

Subtherapeutic Free Phenytoin Levels Following Fosphenytoin Therapy in Status Epilepticus
Neurol 58:147-148, Koul,R. &Deleu,D., 2002

Discontinuing Antiepileptic Drugs in Patients who are Seizure Free on Monotherapy
JNNP 72:22-25,5, Specchio,L.M.,et al, 2002

The Risk-Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Genseng, Echinacea, Saw Palmetto, and Kava
Ann Int Med 136:42-53, Ernst,E., 2002

Almotriptan (AXERT) and Frovatriptan (FROVA) for Migraine
The Medical Letter 44:19-20, , 2002

The Safety of Triptans in the Treatment of Patients with Migraine
Am J Med 112:135-140, Jamieson,D.G., 2002

Therapy for the Epilepsies
Arch Neurol 59:732-735, Van Ness,P.C., 2002

Antiepileptic Drug-Induced Bone Loss in Young Male Patients Who Have Seizures
Arch Neurol 59:781-786, Andress,D.L.,et al, 2002

Effect of Antiepileptic Drugs on Bone Density in Ambulatory Patients
Neurol 58:1348-1353, Farhat,G.,et al, 2002

Alzheimer Disease
JAMA 287:2335-2338, Cummings,J.L. &Cole,G., 2002

A Comparison of Lorazepam,Diazepam,and Placebo for the Treqatment of Out-of-Hospital Status Epilepticus
NEJM 345:631-637,689, Alldredge,B.K.,et al, 2001

Oxcarbazepine (Trileptal) as Monotherapy in Patients with Partial Seizures
Neurol 57:864-871, Sachdeo,R.,et al, 2001

Practice Patterns of Neurologists Regarding Bone and Mineral Effefcts of Antiepileptic Drug Therapy
Arch Neurol 58:1369-1374,1352, Valmadrid,C.,et al, 2001

Uveal Effusion and Secondary Angle-Closure Glaucoma Associated with Topiramate Use
Arch Ophthalmol 119:1210-1211, Sankar,P.S., 2001

Continuous EEG Monitoring and Midazolam Infusion for Refractory Nonconvulsive Status Epilepticus
Neurol 57:1036-1042, Claasen,J.,et al, 2001

Serial EEG During Human Status Epilepticus
Neurol 57:1175-1183, Garzon,E.,et al, 2001

Dysgeusia in Epileptic Patients Treated with Lamotrigine: Report of Three Cases
Neurol 57:1521, Avoni,P.,et al, 2001

Clinical Features of Withdrawal Headache Following Overuse of Triptans and Other Headache Drugs
Neurol 57:1694-1698, Katsarava,Z.,et al, 2001

Randomized Controlled Trial of Zonisamide for the Treatment of Refractory Partial-onset Seizures
Neurol 57:1774-1779, Faught,E.,et al, 2001

Anticipation of Epileptic Seizures from Standard EEG Recordings
Lancet 357:183-188,160, Le Van Quyen,M.,et al, 2001

Weight Change Associated with Valproate and Lamotrigine Monotherapy in Patients with Epilepsy
Neurol 56:172-177, Biton,V.,et al, 2001

Positive Response to Immunommodulatory Therapy in an Adult Patient with Rasmussen's Encephalitis
Neurol 56:248-250, Villani,F.,et al, 2001

Neuropsychological Effects of Epilepsy and Antiepileptic Drugs
Lancet 357:216-222, Kwan,P. &Brodie,M.J., 2001

Safety and Efficacy of Pallidal or Subthalamic Nucleus Stimulation in Advanced PD
Neurol 56:548-551, Volkmann,J.,et al, 2001

Vagus Nerve Stimulation and Drug Reduction
Neurol 56:561-563, Tatum,W.O.,et al, 2001

Chronic Encephalitis and Temporal Lobe Epilepsy: A Variant of Rasmussen's Syndrome?
Neurol 56:678-681, Hennessy,M.J.,et al, 2001

Seizures in Multiple Sclerosis
Epilepsia 42:72-79, Sokic,D.V.,et al, 2001

Rapid Initiation of Gabapentin, A Randomized, Controlled Trial
Neurol 56:743-748, Fisher,R.S.,et al, 2001

Epilepsy
NEJM 344:1145-1151, Browne,T.R. & Holmes,G.L., 2001

Differential Cognitive and Behavioral Effects of Carbamazepine and lamotrigine
Neurol 56:1177-1182, Meador, K.J.,et al, 2001

The Teratogenicity of Anticonvulsant Drugs
NEJM 344:1132-1138, Holmes,L.B.,et al, 2001

Safety of Diastat When Given at Larger-than-recommended Doses for Acute Repetitive Seizures
Neurol 56:1112, Brown,L.,et al, 2001

Benign Intracranial Hypertension Secondary to Nasal Fluticasone Propionate
BMJ 322:897, Bond,D.W.,et al, 2001

Vagal-nerve Stimulation for Epilepsy
Lancet 357:1726-1727, Chadwick,D., 2001

A Randomized, Controlled Trial of Surgery for Temporal-Lobe Eiplepsy
NEJM 345:311-318,365, Wiebe,S.,et al, 2001

Is Carbamazepine Teratogenic? A Prospective Controlled Study of 210 Pregnancies
Neurol 57:321-324, Diav-Citrin,O.,et al, 2001

Lamotrigine Reduces Painful Diabetic Neuropathy
Neurol 57:505-509, Eisenberg,E.,et al, 2001

Delirium From Nicotine Withdrawal in Neuro-ICU Patients
Neurol 57:551-553, Mayer,S.A.,et al, 2001

Adverse Effect of Anticonvulsants on Efficacy of Chemotherapy for Acute Lymphoblastic Leukaemia
Lancet 356:285-290, Relling,M.V. et al, 2000

Management of Epilepsy in Adolescents and Adults
Lancet 356:323-329, Brodie,M.J. & French,J.A., 2000

Anticonvulsant Prophylaxis and Timing of Seizures After Aneurysmal Subarachnoid Hemorrhage
Neurol 55:258-265, Rhoney,D.H. et al, 2000

Levetiracetam for Partial Seizures: Results of A Double-Blind, Randomized Clinical Trial
Neurol 55:236-242, Cereghino,J.J. et al, 2000

Valproate, Hyperandrogenism, and Polycystic Ovaries
Arch Neurol 57:1064-1068, Isojarvi,J.I.T. & Tapanainen,J.S., 2000

Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000

Comparison of Intranasal Midazolam with Intravenous Diazepam for Treating Febril Seizures in Children: Prospective Randomised Study
BMJ 321:83-86,64, Lahat,E. et al, 2000

Hypothermia and Thermoregulatory Derangements Induced by Valproic Acid
Neurol 55:150-151, Zachariah,S.B. et al, 2000

Visual Function Loss From Vigabatrin
Neurol 55:40-45, Johnson,M.A. et al, 2000



Showing articles 450 to 500 of 1447 << Previous Next >>